Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,131 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, not recruiting

Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With Polyangiitis

NCT06230354

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations
  • Aberdeen Royal Infirmary - NHS Grampian Aberdeen, United Kingdom
  • University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
  • Royal Infirmary of Edinburgh - NHS Lothian Edinburgh, United Kingdom
View Trial Details
Active, not recruiting

Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

NCT04898894

Conditions
Acute Leukemia of Ambiguous Lineage in Relapse, Acute Myeloid Leukemia, in Relapse, Hematologic Diseases, +14 more
Locations
  • Rady Children's Hospital-San Diego San Diego, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Childrens Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Active, not recruiting

Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT04384484

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • University of California San Diego Moores Cancer Center La Jolla, California, United States
  • Redlands Community Hospital Redlands, California, United States
  • The Oncology Institute of Hope and Innovation Whittier, California, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
View all 144 locations
View Trial Details
Active, not recruiting

PRospective Multiple Myeloma Impact Study

NCT02911571

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • New York Presbyterian Brooklyn Methodist Hospital Brooklyn, New York, United States
View Trial Details
Active, not recruiting

DS-3201b in Participants With Lymphomas

NCT02732275

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations
  • City of Hope National Medical center Duarte, California, United States
  • Yale University New Haven, Connecticut, United States
  • Emory University Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 20 locations
View Trial Details

Related conditions